MeSH tree: F03.870.400.800.200.750
The way the brain regulates pupil size is different from previously thought: fundamentally responsible is the neurotransmitter orexin, as researchers at ETH Zurich have now shown. This discovery could well alter our understanding ...
Jul 13, 2023
0
59
From sleep trackers to wakefulness drugs, the 21st century has seen an influx of new technology that could radically alter the way we sleep.
May 31, 2023
0
43
The U.S. Food & Drug Administration has approved Lumryz for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy. Lumryz is an extended-release formulation of sodium oxybate to be taken once ...
May 5, 2023
0
89
In a new study, an assistant professor in The University of Texas at Arlington's School of Social Work reports that behavioral health practitioners should more carefully consider sleep health when treating clients struggling ...
Apr 25, 2023
0
61
The nationwide shortages of Adderall that began in fall 2022 have brought renewed attention to the beleaguered drug, which is used to treat attention-deficit/hyperactivity disorder and narcolepsy.
Apr 10, 2023
0
83
Your eyes close and your mind shuts down the second your head hits the pillow, but you wake up 10 hours later still feeling tired.
Mar 15, 2023
0
75
A national shortage of Adderall has people with attention deficit/hyper activity disorder scrambling to find a pharmacy that can refill their prescription.
Oct 28, 2022
0
156
People with attention-deficit/hyperactivity disorder (ADHD) or narcolepsy may rely on the drug Adderall, but it is in short supply, the U.S. Food and Drug Administration announced Wednesday.
Oct 13, 2022
0
83
Emmanuel Mignot is one of the world's leading experts on narcolepsy, a sleep disorder that he finds both "strange" and "fascinating."
Sep 22, 2022
0
57
